ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1001

What Is the Most Cost-Effective Physical Therapy Strategy to Treat Knee Osteoarthritis?

Allyn Bove1, Ken Smith2, Christopher Bise1, Julie Fritz3, John Childs4, Gerard P. Brennan5, J. Haxby Abbott6 and G. Kelley Fitzgerald1, 1Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 2Division of Internal Medicine; Institute for Clinical Research Education, University of Pittsburgh, Pittsburgh, PA, 3Department of Physical Therapy, University of Utah, Salt Lake City, UT, 4US Army-Baylor University, Schertz, TX, 5Rehabilitation Services, Intermountain Healthcare, Murray, UT, 6Centre for Musculoskeletal Outcomes Research, Department of Surgical Sciences, University of Otago, Dunedin, New Zealand

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Economics, Knee, osteoarthritis and physical therapy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: ARHP I: Exemplary Abstracts

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: The American College of Rheumatology (ACR) strongly recommends exercise therapy as a first-line conservative treatment for individuals with knee osteoarthritis (OA).1 Evidence supporting manual therapy for knee OA has shown varying levels of effectiveness.1 In this population, there is minimal research regarding the use of “booster” physical therapy (PT) sessions– visits spaced across a longer period of time to supplement initial treatments.2The purpose of this study was to compare the cost-effectiveness of combinations of exercise therapy and manual therapy with or without booster sessions in individuals with knee OA.

Methods: Data were collected as part of a 2-year multi-site study of 300 individuals who met ACR criteria for knee OA. A Markov model was constructed to compare 4 PT treatment strategies: (1) 12 visits of exercise therapy alone (EX); (2) 9 visits of exercise therapy plus 3 booster sessions spaced across a 12-month period (EX+B); (3) 12 visits of exercise therapy plus manual therapy (EX+MT); (4) 9 visits of exercise therapy plus manual therapy and 3 booster sessions (EX+MT+B). Total health care costs were estimated from the societal perspective using patient reported outcome measures as well as data from the Healthcare Utilization Project and the Medicare physician fee schedule. Utilities were measured using the U.S. version of the Euroqol-5-Dimension tool. Incremental cost-effectiveness ratios (ICERs) are expressed in Quality-Adjusted Life Years (QALYs).

Results: In the 2-year base case analysis, the booster strategies (EX+MT+B and EX+B) dominated (lower health care costs and greater effectiveness) the no-booster strategies (EX+MT and EX). EX+MT+B had the lowest total health care costs. The EX+B group cost $1,061 more and gained 0.082 more QALYs compared with EX+MT+B, for $12,900/QALY gained. In 1-way sensitivity analyses of all parameters, EX+B continued to be cost-effective (<$100,000/QALY gained) compared with EX+MT+B, unless the likelihood of staying in good or poor function was varied to a degree that would be highly improbable given what was observed in this study. In a preliminary model projecting costs and utilities over a 5-year period, the EX+B strategy remained well within the range that most would consider to be cost-effective by third-party payers.  

Conclusion: Spacing exercise-based PT sessions over 12 months using periodic “booster” sessions was less costly and more effective over 2 years than strategies not containing “booster” sessions. Among booster strategies, the group receiving manual therapy in addition to exercise therapy (EX + MT + B) had lower costs but lower gains in QALYs than the EX + B group.

  1. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012;64(2):465-74.
  2. Bennell KL, Kyriakides M, Hodges PW, Hinman RS. Effects of two physiotherapy booster sessions on outcomes with home exercise in people with knee osteoarthritis: a randomized controlled trial. Arthritis Care Res 2014;66(11):1680-7.

Disclosure: A. Bove, None; K. Smith, None; C. Bise, None; J. Fritz, None; J. Childs, None; G. P. Brennan, None; J. H. Abbott, None; G. K. Fitzgerald, None.

To cite this abstract in AMA style:

Bove A, Smith K, Bise C, Fritz J, Childs J, Brennan GP, Abbott JH, Fitzgerald GK. What Is the Most Cost-Effective Physical Therapy Strategy to Treat Knee Osteoarthritis? [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/what-is-the-most-cost-effective-physical-therapy-strategy-to-treat-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-is-the-most-cost-effective-physical-therapy-strategy-to-treat-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology